Rare
lephants
Screener
Toggle theme
Schrödinger, Inc.
SDGR
·
Healthcare, Drug Manufacturers - General, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2020
Total Cash from Operations:
$558.0M
Line Item
Value
% of Total
Capital Expenditures
$2.5M
0.5%
Other Investing
$379.2M
68.0%
Net Cash Flow
$176.3M
31.6%
Download CSV
